These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 4093243

  • 41. Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity.
    du Buf-Vereijken PW, Wetzels JF.
    Nephrol Dial Transplant; 2004 Aug; 19(8):2036-43. PubMed ID: 15187191
    [Abstract] [Full Text] [Related]

  • 42. Cyclophosphamide-induced sister chromatid exchanges in patients with nephrotic syndrome.
    Bogdanović R, Guć-Sśekić M, Pilić G, Cvorić A.
    Child Nephrol Urol; 1990 Aug; 10(3):131-4. PubMed ID: 2285917
    [Abstract] [Full Text] [Related]

  • 43. [Mycophenolate mofetil (MMF) as the first choice immunosuppressive drug in treatment of steroid-dependent nephrotic syndrome in children].
    Ogarek I, Szczęsny-Choruz E, Wierzchowska-Słowiaczek E, Kwinta-Rybicka J, Stec Z, Moczulska A, Wilkosz K, Drożdż D.
    Pol Merkur Lekarski; 2018 Apr 23; 44(262):192-195. PubMed ID: 29775447
    [Abstract] [Full Text] [Related]

  • 44. Stevens-Johnson syndrome during an immunosuppressive therapy with cyclophosphamide and prednisone.
    Leititis JU, Burghard R, Rietschel E, Rieger CH, Brandis M.
    Klin Padiatr; 1985 Apr 23; 197(5):441-2. PubMed ID: 4068604
    [Abstract] [Full Text] [Related]

  • 45. Cyclophosphamide and rituximab in frequently relapsing/steroid-dependent nephrotic syndrome.
    Webb H, Jaureguiberry G, Dufek S, Tullus K, Bockenhauer D.
    Pediatr Nephrol; 2016 Apr 23; 31(4):589-94. PubMed ID: 26525199
    [Abstract] [Full Text] [Related]

  • 46. Acute lymphoblastic leukaemia after treatment of nephrotic syndrome with immunosuppressive drugs.
    Kuis W, de Kraker J, Kuijten RH, Donckerwolcke RA, Voûte PA.
    Helv Paediatr Acta; 1976 Jun 23; 31(1):91-5. PubMed ID: 1065623
    [Abstract] [Full Text] [Related]

  • 47. Beneficial effect of second courses of cytotoxic therapy in children with minimal change nephrotic syndrome.
    Jones DP, Stapleton FB, Roy S, Wyatt RJ.
    Pediatr Nephrol; 1988 Jul 23; 2(3):291-5. PubMed ID: 3153028
    [Abstract] [Full Text] [Related]

  • 48. Intravenous cyclophosphamide in steroid-resistant nephrotic syndrome.
    Bajpai A, Bagga A, Hari P, Dinda A, Srivastava RN.
    Pediatr Nephrol; 2003 Apr 23; 18(4):351-6. PubMed ID: 12700961
    [Abstract] [Full Text] [Related]

  • 49. Cyclophosphamide treatment of steroid dependent nephrotic syndrome: comparison of eight week with 12 week course. Report of Arbeitsgemeinschaft für Pädiatrische Nephrologie.
    Arch Dis Child; 1987 Nov 23; 62(11):1102-6. PubMed ID: 3688915
    [Abstract] [Full Text] [Related]

  • 50. Cyclophosphamide in steroid-sensitive nephrotic syndrome: outcome and outlook.
    Vester U, Kranz B, Zimmermann S, Hoyer PF.
    Pediatr Nephrol; 2003 Jul 23; 18(7):661-4. PubMed ID: 12750975
    [Abstract] [Full Text] [Related]

  • 51. [Ifosfamide in the treatment of nephrotic syndrome (author's transl)].
    Gekle D, Daigeler C.
    Klin Padiatr; 1977 Sep 23; 189(5):370-5. PubMed ID: 562447
    [Abstract] [Full Text] [Related]

  • 52. Unfavorable response to cyclophosphamide in steroid-dependent nephrotic syndrome.
    Kemper MJ, Altrogge H, Ludwig K, Timmermann K, Müller-Wiefel DE.
    Pediatr Nephrol; 2000 Aug 23; 14(8-9):772-5. PubMed ID: 10955925
    [Abstract] [Full Text] [Related]

  • 53. Steroid-responsive nephrotic syndrome of childhood: a long-term study of clinical course, histopathology, efficacy of cyclophosphamide therapy, and effects on growth.
    Berns JS, Gaudio KM, Krassner LS, Anderson FP, Durante D, McDonald BM, Siegel NJ.
    Am J Kidney Dis; 1987 Feb 23; 9(2):108-14. PubMed ID: 3826059
    [Abstract] [Full Text] [Related]

  • 54. Long-term follow-up after cyclophosphamide therapy in steroid-dependent nephrotic syndrome.
    Zagury A, de Oliveira AL, de Moraes CA, de Araujo Montalvão JA, Novaes RH, de Sá VM, Monteiro de Carvalho Dde B, Matuck T.
    Pediatr Nephrol; 2011 Jun 23; 26(6):915-20. PubMed ID: 21399901
    [Abstract] [Full Text] [Related]

  • 55. [Hazard-adapted therapy of acquired idiopathic nephrotic syndromes in children].
    Olbing H.
    Dtsch Med Wochenschr; 1973 May 25; 98(21):1079-85. PubMed ID: 4196141
    [No Abstract] [Full Text] [Related]

  • 56. Levamisole in children's idiopathic nephrotic syndrome.
    La Manna A, Polito C, Del Gado R, Foglia AC.
    Child Nephrol Urol; 1973 May 25; 9(4):200-2. PubMed ID: 3255483
    [Abstract] [Full Text] [Related]

  • 57. Nitrogen mustard therapy in idiopathic nephrotic syndrome of childhood.
    Broyer M, Meziane A, Kleinknecht C, Niaudet P.
    Int J Pediatr Nephrol; 1985 May 25; 6(1):29-34. PubMed ID: 3997369
    [Abstract] [Full Text] [Related]

  • 58. Minimal-lesion nephrotic syndrome with early resistance to steroid therapy.
    Siegel NJ, Gur A, Krassner LS, Kashgarian M.
    J Pediatr; 1975 Sep 25; 87(3):377-80. PubMed ID: 1165516
    [Abstract] [Full Text] [Related]

  • 59. Cyclosporin A in nephrotic syndrome of childhood--a 14 month experience.
    Capodicasa G, De Santo NG, Nuzzi F, Giordano C.
    Int J Pediatr Nephrol; 1986 Sep 25; 7(2):69-72. PubMed ID: 3522457
    [Abstract] [Full Text] [Related]

  • 60. Prolonged versus standard prednisolone therapy for initial episode of nephrotic syndrome.
    Bagga A, Hari P, Srivastava RN.
    Pediatr Nephrol; 1999 Nov 25; 13(9):824-7. PubMed ID: 10603129
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.